BioNTech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 08/10/22 EDT
160.92UNCH (UNCH)
Volume
5,222,269
Close
160.92quote price arrow down-12.09 (-7.14%)
52 week range
117.08 - 464.00
Loading...
  • Open162.24
  • Day High162.30
  • Day Low156.62
  • Prev Close157.21
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low117.08
  • 52 Week Low Date06/22/22

Key Stats

  • Market Cap39.054B
  • Shares Out242.69M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.07
  • YTD % Change-37.58

KEY STATS

  • Open162.24
  • Day High162.30
  • Day Low156.62
  • Prev Close157.21
  • 52 Week High464.00
  • 52 Week High Date08/10/21
  • 52 Week Low117.08
  • 52 Week Low Date06/22/22
  • Market Cap39.054B
  • Shares Out242.69M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-0.07
  • YTD % Change-37.58

RATIOS/PROFITABILITY

  • EPS (TTM)47.15
  • P/E (TTM)3.41
  • Fwd P/E (NTM)6.47
  • EBITDA (TTM)15.815B
  • ROE (TTM)105.30%
  • Revenue (TTM)21.638B
  • Gross Margin (TTM)81.82%
  • Net Margin (TTM)55.44%
  • Debt To Equity (MRQ)1.42%

EVENTS

  • Earnings Date11/07/2022(est)
  • Ex Div Date06/02/2022
  • Div Amount2.1322
  • Split Date-
  • Split Factor-

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. It develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company...
Ugur Sahin M.D.
Chief Executive Officer, Member of the Management Board
Sierk Poetting
Chief Operating Officer, Member of the Management Board
Jens Holstein
Chief Financial Officer
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
MRNA
Moderna Inc
174.27-11.80-6.45%
REGN
Regeneron Pharmaceuticals Inc
641.49-8.48-1.34%
BIIB
Biogen Inc
221.04+0.03+0.01%
ILMN
Illumina Inc
227.30-8.18-3.67%
ALNY
Alnylam Pharmaceuticals Inc
232.00-7.37-3.19%